Biotin patent: dsm-firmenich secures CN¥8.1M compensation in Chinese court

A court in Anhui Province, China, ruled that a local company infringed on dsm-firmenich’s patent (Patent # ZL 200480008505.7) on the intermediate production technology for biotin — also known as vitamin B7 or vitamin H. 

The court is granting dsm-firmenich CN¥8.1M (US$1.1M) in the case against Shengda (Zhejiang Shengda Bio-pharm and Anhui Shengda Bio-pharm). Shengda has appealed the judgment, while dsm-firmenich seeks a greater sum.